Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-03

Clinical Trial Update: Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT [Phase 2]

View source ↗

Summary

This is a Phase 2 pilot randomized trial evaluating intranasal oxytocin for benzodiazepine withdrawal in people with benzodiazepine dependence. Recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Benzodiazepine Dependence | Phase 2 | Status: RECRUITING